Ownership history in Bleichroeder LP · 5 quarters on record
This page tracks every 13F SEC filing in which Bleichroeder LP reported a position in EVOKE PHARMA INC (EVOK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 146,395 | +77,645 | +112.9% | 0.14% | $728K | — |
| 2025 Q2 | UNCHANGED | 68,750 | — | 0% | 0.04% | $179K | — |
| 2025 Q1 | UNCHANGED | 68,750 | — | 0% | 0.05% | $189K | — |
| 2024 Q4 | UNCHANGED | 68,750 | — | 0% | 0.08% | $304K | — |